Immunostimulatory DNA-based vaccines elicit multifaceted immune responses against HIV at systemic and mucosal sites

Journal of Immunology

Volumn 167, Issue 3, 2001, Pages 1584-1591

  Horner, A A ^a   Datta, S K ^a   Takabayashi, K ^a   Belyakov, I M ^a   Hayashi, T ^a   Cinman, N ^a   Nguyen, M D ^a   Van Uden, J H ^a   Berzofsky, J A ^a   Richman, D D ^a   Raz, E ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR5; DNA VACCINE; GAMMA INTERFERON; GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; CPG ISLAND; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DNA SEQUENCE; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSTIMULATION; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; VACCINATION;

EID: 0035423454     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.3.1584     Document Type: Article

References (62)

1. Introduction: The role of innate immunity in the adaptive immune response
2. Recognition of Gram-negative bacteria and endotoxin by the innate immune system
3. Mechanisms of phagocytosis in macrophages
4. The instructive role of innate immunity in the acquired immune response
5. PKR: A sentinel kinase for cellular stress
6. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon γ
7. CpG motifs in bacterial DNA trigger direct B-cell activation
8. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants
9. DNA activates human immune cells through a CpG sequence-dependent manner
10. Enhancement of antigen-presenting cell surface molecules involved in cognate interactions by immunostimulatory DNA sequences
11. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells
12. Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism
13. Functions for DNA methylation in vertebrates
14. Functional role of type I and type II interferons in antiviral defense
15. Synthetic oligonucleotides with particular base sequences from the cDNA encoding proteins of Mycobacterium bovis BCG induce interferons and activate natural killer cells
16. A Toll-like receptor recognizes bacterial DNA
17. DNA-PKcs is required for activation of innate immunity by immunostimulatory DNA
18. Natural adjuvants: Endogenous activators of dendritic cells
19. Conjugation of protein to immunostimulatory DNA results in a rapid long-Lasting potent induction of cell-mediated humoral immunity
20. + cytotoxic T lymphocytes for resistance to mucosal viral transmission in mice and enhancement of resistance by local administration of IL-12
21. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization
22. An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class 1 major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes
23. Molecular analysis of the same HIV peptide functionally binding to both a class I and a class II MHC molecule
24. Immunostimulatory CpG motifs trigger a T helper-1 immune response to human immunodeficiency virus type-I (HIV-1) gp 160 envelope proteins
25. In vitro immune function after vaccination with an inactivated, gp120-depleted HIV-1 antigen with immunostimulatory oligodeoxynucleotides
26. Human immunodeficiency virus (HIV)-specific immune responses are generated with the simultaneous vaccination of a gp120-depleted, whole-killed HIV-1 immunogen with cytosine-phosphorothioate-guanine dinucleotide immunostimulatory sequences of DNA
27. Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity
28. Regulation of murine airway eosinophilia and Th2 cells by antigen-conjugated CpG oligodeoxynucleotides as a novel antigen-specific immunomodulator
29. A vaccine for HIV type I: The antibody perspective
30. Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1: The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group
31. To kill or to cure: Options in host defense against viral infection
32. Immune defence in mice lacking type I and/or type II interferon receptors
33. CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1
34. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
35. Identification of a major co-receptor for primary isolates of HIV-1
36. A dual-tropic primary HIV-1 isolate that uses fuscin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors
37. + cells is mediated by the chemokine receptor CC-CKR-5
38. + T cells
39. + T cell depletion and viral replication in SIV infection
40. Long-lived cytotoxic T lymphocyte memory in mucosal tissues after mucosal but not systemic immunization
41. T cell responses and viral escape
42. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type I infection
43. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA
44. + cells: Evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms
45. + lymphocytes can control HIV infection in vitro by suppressing virus replication
46. Immunostimulatory DNA is a potent mucosal adjuvant
47. CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice
48. CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus
49. HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers
50. Protection of the villus epithelial cells of the small intestine from rotavirus infection does not require immunoglobulin A
51. Immunoglobulin G is the main protective antibody in mouse vaginal secretions after vaginal immunization with attenuated herpes simplex virus type 2
52. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen
53. CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: A new class of vaccine adjuvants
54. Help for cytotoxic-T-cell responses is mediated by CD40 signalling
55. + T-helper and a T-killer cell
56. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions
57. CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by nonspecific endocytosis and endosomal maturation
58. Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6
59. + memory T cells by opposing cytokines
60. + T cells in vivo by IL-15
61. HIV-1-specific cell-mediated immune responses induced by DNA vaccination were enhanced by mannan-coated liposomes and inhibited by anti-interferon-γ antibody
62. Enhancement of clearance of bacteria from murine lungs by immunization with detoxified lipooligosaccharide from Moraxella catarrhalis conjugated to proteins